Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayato Tada

Showing results (21-30 of 306) with videos related to

Pageof 31
Sort By:
Journal of Atherosclerosis and Thrombosis|January 29, 2023
What is the Role of Cholesterol Absorption and Synthesis Biomarkers in Humans?Hayato Tada, Nobuko Kojima, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|December 17, 2025
Genetic Testing for Children with Familial HypercholesterolemiaKeiko Nagahara, Hayato Tada, Kazushige Dobashi
Atherosclerosis Plus|July 2, 2026
Effects of evolocumab on plasma coenzyme Q10 in patients with heterozygous familial hypercholesterolemiaHayato Tada, Yasuaki Takeji, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|September 20, 2023
Comparative Effects of Genetic and Nongenetic Factors in Antithrombotic StrategyTakuya Nakahashi, Kenji Sakata, Hayato Tada
Journal of Atherosclerosis and Thrombosis|March 9, 2025
What's the Ultimate Risk Score for CAD Patients?Yasuaki Takeji, Hayato Tada, Masayuki Takamura
Journal of Clinical Lipidology|August 5, 2022
Familial hypobetalipoproteinemia caused by homozygous loss-of-function mutations in PCSK9: A case reportTakanori Kudo, Kei Sasaki, Hayato Tada
Journal of Atherosclerosis and Thrombosis|January 15, 2023
Exquisite Balance Between Cholesterol Synthesis and Cholesterol Absorption in HumanHayato Tada, Nobuko Kojima, Masayuki Takamura
Current Opinion in Cardiology|November 19, 2016
The genetics of atrial fibrillationKenshi Hayashi, Hayato Tada, Masakazu Yamagishi
Internal Medicine (Tokyo, Japan)|March 25, 2025
A Case with Oligogenic Familial Hypercholesterolemia Treated by Combination Therapy of Statin, Ezetimibe, PCSK9 Inhibitor, and LomitapideNobuko Kojima, Hayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|February 28, 2024
Assessment of Venous Thromboembolism Risk of Antipsychotic Drugs Using Mendelian Randomization AnalysisHirofumi Okada, Hayato Tada, Masayuki Takamura
Pageof 31

Showing results (21-30 of 306) with videos related to

Sort By:
Pageof 31
Journal of Atherosclerosis and Thrombosis|January 29, 2023
What is the Role of Cholesterol Absorption and Synthesis Biomarkers in Humans?Hayato Tada, Nobuko Kojima, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|December 17, 2025
Genetic Testing for Children with Familial HypercholesterolemiaKeiko Nagahara, Hayato Tada, Kazushige Dobashi
Atherosclerosis Plus|July 2, 2026
Effects of evolocumab on plasma coenzyme Q10 in patients with heterozygous familial hypercholesterolemiaHayato Tada, Yasuaki Takeji, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|September 20, 2023
Comparative Effects of Genetic and Nongenetic Factors in Antithrombotic StrategyTakuya Nakahashi, Kenji Sakata, Hayato Tada
Journal of Atherosclerosis and Thrombosis|March 9, 2025
What's the Ultimate Risk Score for CAD Patients?Yasuaki Takeji, Hayato Tada, Masayuki Takamura
Journal of Clinical Lipidology|August 5, 2022
Familial hypobetalipoproteinemia caused by homozygous loss-of-function mutations in PCSK9: A case reportTakanori Kudo, Kei Sasaki, Hayato Tada
Journal of Atherosclerosis and Thrombosis|January 15, 2023
Exquisite Balance Between Cholesterol Synthesis and Cholesterol Absorption in HumanHayato Tada, Nobuko Kojima, Masayuki Takamura
Current Opinion in Cardiology|November 19, 2016
The genetics of atrial fibrillationKenshi Hayashi, Hayato Tada, Masakazu Yamagishi
Internal Medicine (Tokyo, Japan)|March 25, 2025
A Case with Oligogenic Familial Hypercholesterolemia Treated by Combination Therapy of Statin, Ezetimibe, PCSK9 Inhibitor, and LomitapideNobuko Kojima, Hayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|February 28, 2024
Assessment of Venous Thromboembolism Risk of Antipsychotic Drugs Using Mendelian Randomization AnalysisHirofumi Okada, Hayato Tada, Masayuki Takamura
Pageof 31